Dabigatran | Rivaroxaban | |
---|---|---|
Number of patients captured | 27 | 6 |
Mean CHA2DS2VASc score when internally initiated Mean CHA2DS2VASc score when externally initiated | 3.3 (range 2–6) 3.3 (range 0–8) | 4 (range 2–7) N/A |
Mean HAS-BLED score when internally initiated Mean HAS-BLED score when externally initiated | 1.25 (range 1–3) 1.6 (range 1–3) | 1.5 (range 0–3) N/A |
Reasons for initiation of NOACs over warfarin Labile INR Unable to comply with warfarin monitoring Allergy/intolerance to warfarin Other | 10 9 7 1 | 2 2 2 0 |
Patients receiving reduced doses Due to impaired renal function Due to age Due to high bleeding risk Due to interacting drugs according to licence Due to GORD No clear indication | 24 5 6 2 2 1 8 | 3 3 0 0 0 0 0 |